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Response of conductance and resistance 
coronary vessels to scalar concentrations of 
acetylcholine: Assessment with quantitative 
angiography and intracoronary Doppler 
echography in 29 patients with coronary artery 
disease 
Abnormal vasoreactivity of the large conductance arteries has been observed in the presence of 
impaired endothelial function. More recently, experimental and clinical reports have shown that in 
early coronary atherosclerosis the impairment of the endothelium-mediated vasodilatation also 
involves the resistance arteries. The aim of this study is the correlation of endothelium- 
dependent vasodilatation of conductance and resistance vessels in coronary arteries without 
significant stenoses. In 29 patients (aged 57 f  9 years, 24 men and 5 women) undergoing 
coronary angioplasty, a Doppler guide wire and a perfusion catheter were introduced into the 
proximal segment of an artery with less than 30% diameter stenosis. Selective infusions of 
papaverine (bolus of 7 mg), acetylcholine (continuous infusion of 0.036, 0.36, and 3.6 Ag/ml at a 
flow rate of 2 mllmin), and isosorbide dinitrate (bolus of 3 mg) were sequentially performed. 
Heart rate, aortic blood pressure, and blood flow velocity were continuously measured. Mean 
cross-sectional areas of a proximal and a distal arterial segment were measured in baseline 
conditions, at the end of each infusion of acetylcholine, and at the peak effect of isosorbide 
dinitrate with quantitative angiography (CAAS System; Pie Medical Data, Maastricht, The 
Netherlands). Coronary blood flow was calculated from the time-averaged flow velocity and the 
cross-sectional area at the site of the Doppler sample volume. Coronary flow resistance was 
calculated as mean aortic pressure divided by coronary flow. All of the concentrations of 
acetylcholine induced a significant vasoconstriction of the studied artery. At the maximal 
concentration of acetylcholine all but three patients (90%) showed a reduction of cross-sectional 
area (-24% -t 20% and -22% + 20% for the proximal and distal segments, respectively, 
p < 0.00001). Flow velocity showed a significant increase only with the two highest 
concentrations of acetylcholine. The maximal concentration induced a 105% f  136% increase 
from the baseline flow velocity (p < 0.001). The coronary flow changes after acetylcholine 
showed a large interpatient variability, with a mean increase from baseline after the highest dose 
of +43% + 65% (range, -60% + 239%), with the presence of a flow reduction in 10 patients 
(35%). No clinical or angiographic variables showed a significant correlation with the 
cross-sectional area, flow velocity, and flow changes after infusion of acetylcholine. After 
acetylcholine infusion, angiographically normal or minimally diseased arteries of patients with 
symptoms of coronary artery disease show: (1) a significant coronary vasoconstriction of the 
epicardial arteries; (2) a variable change in coronary flow, with a trend toward a moderate 
increase; and (3) a dissociation between the impairment of endothelium-mediated vasodilatation 
of conductance and resistance vessels, suggesting the presence of different mechanisms 
underlying the endothelial dysfunction in these two arterial districts. (AM HEART J 
1994;127:514-31.) 
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The in vitro observations of Furchgott and Zawadz- 
kil and the results of in vitro and in vivo studies by 
Palmer et al. and Valiance et a1.3 have shown that an 
endothelium-derived relaxing factor, identified as 
nitric oxide,2 modulates vascular tone in response to 
physiologic and pathologic stimuli (increase in wall 
shear stress, serotonin, bradykinin, histamine, throm- 
bin, sympathetic stimulation, acetylcholine, endo- 
toxins, etc.). Endothelial damage, leading to a de- 
creased formation or release of nitric oxide from its 
precursor L-arginine, or reduced penetration caused 
by the presence of subendothelial intimal thickening, 
are possible explanations of the impairment of en- 
dothelium-mediated vasodilatation observed in pa- 
tients with systemic hypertension4 hypercholester- 
olemia, diabetes mellitus5 or atherosclerosis.6 
The presence of paradoxical vasoconstriction in- 
duced by acetylcholine has been shown in patients 
with coronary artery disease at sites of severe steno- 
sis or moderate wall irregularities7 and in angio- 
graphically normal segments.8-10 Coronary spasm 
after acetylcholine infusion has also been demon- 
strated in patients with variant angina, with and 
without angiographically visible changes.ll? l2 The 
observed vasoconstriction or vasodilatation after 
acetylcholine infusion is the net effect of the con- 
flicting action of this substance on the endothelial 
cells (stimulation to the release of endothelium- 
derived relaxing factor) and on the smooth muscle 
cells (vasoconstriction caused by the direct effect on 
the cholinergic receptors). With the use of intracor- 
onary Doppler echography, an impairment of the en- 
dothelium-derived vasodilatation was also observed 
after more physiologic stimuli such as an increase in 
blood flow.13-l5 Flow-dependent vasodilatation is an 
essential mechanism of adjustment of coronary tone 
to prevent endothelial damage caused by a pathologic 
increase in wall shear stress.12 Abnormal vasocon- 
striction in response to sympathetic stimulation16 or 
release of platelet-derived vasoconstrictors173 l8 was 
observed if the direct effect of these substances on the 
muscular media was not antagonized by a preserved 
endothelium-mediated vasodilatation. Nitric oxide 
also has a powerful antiaggregatory activity. Yao et 
al.lg showed a protective effect of endogenous nitric 
oxide in the prevention of cyclic flow variations 
caused by platelet aggregation at the site of endothe- 
lial injury. Endothelial dysfunction therefore is not 
only a potential mechanism of aggravation of ische- 
mia in patients with coronary atherosclerosis; it also 
increases the risk of endothelial injury and impairs 
the antithrombotic reaction, thus facilitating the de- 
velopment of acute coronary syndromes and the re- 
lease of platelet-derived growth factors, which may 
predispose patients to progression of atherosclerosis. 
An impairment of endothelium-mediated vasodila- 
tation has been shown in patients with risk factors for 
coronary atherosclerosis but without angiographi- 
tally visible atherosclerotic changes.gT 2o A possible 
limitation of these studies is the poor sensitivity of 
angiography in the detection of early atherosclerotic 
changes. More recently, the presence of endothelial 
dysfunction in patients with structurally normal 
coronary arteries but with hypertension, hyperlipi- 
demia, family history of coronary artery disease or 
smoking has been confirmed with two-dimensional 
intracoronary ultrasound. 21 A complete loss of en- 
dothelium-mediated vasodilatation was present in 
arteries with angiographically visible atherosclerotic 
changes. Angiographically normal arteries of pa- 
tients with hypercholesterolemia showed a normal 
flow-mediated vasodilatation after infusion of papa- 
verine but an abnormal vasoconstriction after infu- 
sion of acetylcholine.21 
The possible presence of opposite effects of acetyl- 
choline infusion on epicardial and resistance coro- 
nary arteries have been reported by Hodgson and 
Marshall.22 The observed increase of coronary flow 
after acetylcholine infusion was prevented by pre- 
treatment with methylene blue, an inhibitor of en- 
dothelium-derived relaxing factor. Zeiher et a1.23 
reported a significantly lower flow increase after ace- 
tylcholine infusion in patients with coronary artery 
disease than in control subjects. These findings con- 
firmed previous experimental results showing that 
the impairment of endothelial function in athero- 
sclerotic arteries may extend into the coronary mi- 
crocirculation.24-26 The presence of an impaired 
endothelium-dependent vasodilatation of the resis- 
tance vessels may induce or facilitate the develop- 
ment of myocardial ischemia in response to neuro- 
humoral stimulation or increased myocardial work.27 
The epicardial arteries and the arterioles have large 
structural differences and show a different involve- 
ment in the atherosclerotic process, mainly confined 
to the large epicardial coronary arteries. Both types 
of arteries, however, are likely to show a similar re- 
sponse to pathologic stimuli on the endothelial cells, 
impairing the intracellular production and release of 
nitric oxide. The presence of an impaired diffusion or 
of an increased extracellular degradation of nitric 
oxide in the thickened intima is a phenomenon lim- 
ited to the epicardial arteries and may explain an 
earlier and more severe impairment of the endothe- 
lium-mediated vasodilatation of these vessels. 
The aim of this study is the simultaneous assess- 
ment of the endothelium-mediated vasodilatation of 
conductance and resistance vessels in coronary ar- 
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teries without significant stenosis (<30 % diameter 
stenosis). During selective infusion of scalar increas- 
ing concentrations of acetylcholine, the changes of 
coronary cross-sectional area over a proximal or mid 
segment and a distal segment of the studied artery 
were measured with quantitative coronary angiogra- 
phy and correlated with the changes in coronary flow, 
derived from the flow velocity measured with a Dop- 
pler guide wire and used as an index of vasodilatory 
response of the resistance vessels. 
METHODS 
Patient population. Twenty-nine patients (aged 57 * 9 
years, 24 men and 5 women) who were undergoing elective 
percutaneous transluminal angioplasty because of dis- 
abling stable angina pectoris were studied. Previous myo- 
cardial infarction was present in 8 of 29 patients (26 % ); in 
no case was the territory of distribution of the studied ar- 
tery involved. Systemic hypertension was defined as a 
chronically elevated arterial blood pressure (L 150/90 mm 
Hg) and was present in 9 of 29 patients (31%). Three pa- 
tients were current smokers (10%). A history of smoking 
was present in 18 patients (62%). No patient had anemia 
(mean hemoglobin, 8.8 f  0.57 mmol/L) or anamnestic or 
biohumoral signs of diabetes mellitus or hyperthyroidism. 
The angiographic selection criteria included less than 
30% diameter stenosis in one of the three major coronary 
arteries without visible collaterals originating from this 
vessel and with a normal left ventricular contraction of the 
segments of distribution of the studied artery. Angiograph- 
ically visible wall irregularities were present in 19 of 29 pa- 
tients (66%). The studied artery was the left anterior de- 
scending coronary artery in seven patients (24 % ), the left 
circumflex coronary artery in 13 (45%), and the right cor- 
onary artery in nine (31%). Written informed consent was 
obtained in all cases. The protocol was approved by the 
Ethics Committee of Erasmus University-Rotterdam Di- 
jkzigt Hospital. All vasoactive medication, with the excep- 
tion of short-acting sublingual nitrates, was withheld for at 
least 48 hours before the catheterization. No sublingual, 
intravenous, or intracoronary nitrates were used in the 6 
hours before or during the catheterization procedure. 
Catheterization procedure. After systemic anticoagu- 
lation with 10,000 IU of heparin and 250 mg of acetylsal- 
icylic acid administered intravenously and sedation with 5 
to 10 mg diazepam administered intravenously, the artery 
to be studied was instrumented with a 9F giant lumen (in- 
ner lumen = 0.084 inches) Amplatz or Judkins guiding 
catheter (left coronary artery) or a 7F Judkins diagnostic 
catheter (right coronary artery). A 0.018 inch Doppler an- 
gioplasty guide wire was then advanced to a normal or 
near-normal straight proximal segment of the artery to be 
studied where a stable flow velocity signal could be ob- 
tained. A 3.6F flexible infusion catheter (Tracker 25, Tar- 
get Therapeutics, San Jose, Calif.) was then inserted over 
the Doppler wire into the proximal segment of the coronary 
artery to obtain a selective injection into the left anterior 
descending or left circumflex coronary artery.“’ Care was 
taken to avoid a too selective cannulation of the large 
guiding catheter into the left main coronary artery to pre- 
vent limitation of flow during maximal hyperemia. For the 
right coronary artery a selectively engaged 7F diagnostic 
catheter was used for the injection. Heart rate and mean 
aortic pressure were automatically measured with a previ- 
ously described computer-assisted systemZg by averaging 
16 consecutive seconds of recording. After baseline acqui- 
sition of flow velocity, heart rate, and blood pressure, the 
measurements were repeated 30 seconds after a bolus 
injection of 7 mg of papaverine diluted in 1.5 ml. After a 
recovery period of 8 minutes, new basal measurements 
were performed, followed by a cineangiogram suitable for 
quantitation. Scalar concentrations of acetylcholine (Dis- 
persa, Wintertaur, Switzerland) at 37’ C (0.036, 0.36, Fg/ 
ml) were infused at a flow rate of 2 ml/min with a precision 
pump-injector (Mark V, Medrad, Pittsburgh, Pa.). With 
these dilutions and flow rates and assuming a coronary 
blood flow of 80 ml/min in the studied artery, intracoronary 
blood concentrations of 10ms, 10m7, and 10-s mol/L were 
estimated. Five minutes after the beginning of the infusion 
of each concentration, blood flow velocity and hemody- 
namic measurements were obtained, and a new cineangio- 
gram was performed. Five minutes after the end of the se- 
ries of acetylcholine infusions, a new baseline flow velocity 
was obtained, and 1 minute after a bolus injection of 3 mg 
of isosorbide dinitrate, a new cineangiogram was per- 
formed. 
Doppler guide wire and flow velocity measurements. 
The Doppler angioplasty guide wire is an 0.018 inch 
(diameter = 0.46 mm), 175 cm long flexible and steerable 
guide wire with a floppy shapable distal end mounting a 12 
MHz piezoelectric transducer at the tip (FloWire, Cardio- 
metrics Inc., Mountain View, Calif.). The sample volume 
was positioned at a distance of 5.2 mm from the transducer 
to avoid the area of distortion of flow profile caused by the 
presence of the Doppler guide wire. At this distance the 
sample volume has a diameter of approximately 2.25 mm 
because of the divergent ultrasound beam, so that a large 
part of the flow velocity profile is included in the sample 
volume even in case of eccentric position of the Doppler 
guide wire. In order to increase the reliability of the anal- 
ysis of the Doppler signal,“O a real-time fast-Fourier trans- 
form algorithm was applied to the quadrature audio signal. 
The Doppler system used (FloMap, Cardiometrics Inc.) 
performs a real-time spectral analysis of the Doppler sig- 
nal and calculates and displays on-line several spectral 
variables including the instantaneous peak velocity and the 
time-averaged (mean of 2 beats) peak velocity (Fig. 1). The 
flow velocity measurements obtained with this system have 
been validated in vitro and in an animal model in which si- 
multaneous electromagnetic flow measurements were used 
for comparison. 31 Coronary flow reserve was defined as the 
ratio between maximal flow velocity at the peak effect of 
the papaverine injection and in baseline conditions. ECG, 
coronary pressure, and peak coronary blood flow velocity 
were continuously sampled at 125 kHz per channel with a 
12-bits analog-to-digital converter. The ACodas software 
package (Data& Instr., Akron, Ohio) was used for off-line 
analysis. 
Quantitative angiographic measurements. The pre- 
formed coronary catheter, filmed not filled with contrast 
medium, was used as a scaling device.32 Before the study. 
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Fig. 1. Flow velocity measurement in proximal left circumflex artery before injection of increasing con- 
centrations of acetylcholine (baseline 2), 5 min after end of infusion of acetylcholine (baseline 3), and at 
peak effect of papaverine (lower left) and acetylcholine 10e6 mol/L (lower right). Note the stable flow ve- 
locity in baseline condition, large velocity increase after infusion of papaverine, and moderate increase af- 
ter infusion of maximal concentration of acetylcholine. 
Fig. 2. Quantitative angiographic measurements of mean diameter of a proximal segment of left circum- 
flex artery. Two side branches are used as landmarks to facilitate consistent repeated measurements of same 
segment throughout procedure. Note severe decrease in mean coronary diameter (-22 % ) after maximal 
concentration of acetylcholine (ACH 10m6 M). ISDN, Isosorbide dinitrate. 
when necessary, a previously validated on-line analysis 
system operating on digital images (ACA-DCI, Philips, 
Eindhoven, The Netherlands)33 was used to exclude the 
presence of more than 30% diameter stenosis. Coronary 
angiography was performed with a manual injection of 6 to 
10 ml of iopamidol (lopamiro 370, Schering, Berlin, Ger- 
many). A 5- or 7-inch field-of-view of the image intensifier 
was used. No changes of the position of the patient or of the 
x-ray gantry were performed throughout the procedure. 
The same angiographic view was maintained during the 
study, avoiding foreshortening or vessel superimposition of 
the arterial segments of interest. A previously validated34 
cinefilm-based off-line system (CAAS System, Pie Medical 
Data, Maastricht, The Netherlands) was used to measure 
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Fig. 3. A, Heart rate. B, Mean aortic blood pressure during various phases of the study. ACH, Acetylcho- 
line; BAS, baseline; ISDN, isosorbide dinitrate; PAP, papaverine. 
the mean diameter over a 2 to 3 cm long proximal or mid (diagonal, obtuse marginal, posterolateral, right ventricu- 
segment and distal coronary segment; easily visible side lar branch) was analyzed as a distal segment. In the 
branches were used as anatomic landmarks to allow the remaining 15 (52%) cases the distal segment of one of the 
analysis of the same segments in successive cineangiograms three major coronary arteries was used. The quantitative 
(Fig. 2). In 14 cases (48%) a second-order arterial branch angiographic system used automatically detects the vessel 
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Fig, 4. Flow velocity changes expressed as a percent of baseline flow velocity. ACH, Acetylcholine; BAS, 
baseline; ISDN, isosorbide dinitrate; PAP, papaverine. 
centerline and applies a weighted first- and second-deriv- 
ative function with predetermined continuity constraints 
to the brightness profile of each scan line perpendicular to 
the vessel centerline.35 A user-defined reference diameter 
was measured at the site of the Doppler sample volume.36 
Cross-sectional area was calculated from the corresponding 
diameter, assuming a circular arterial cross-section. Coro- 
nary flow was calculated as: Coronary flow (ml/min) = CSA 
(mm2) x Time-averaged peak velocity (cm/s) + 2 x 0.6, 
where CSA is the arterial cross-sectional area at the site of 
the Doppler sample volume. Coronary flow resistance was 
calculated as: Coronary flow resistance (mm Hg min 
ml-‘) = Mean aortic pressure (mm Hg) + Coronary flow 
(ml/min). 
Statistical analysis. The significance of the differences 
between flow velocity and cross-sectional area measure- 
ments and derived indexes in baseline conditions and after 
papaverine, acetylcholine, and isosorbide dinitrate infu- 
sions was tested with a two-tailed Student’s t test for paired 
data. A two-tailed Student’s t test for unpaired data war 
used to compare the diameter and flow changes observed 
in patients with different clinical angiographic character- 
istics. Linear regression analysis was used to correlate the 
changes observed in cross-sectional area, in coronary flow, 
and in coronary flow resistance. Analysis of variance for 
repeated measurements was used to test the time-response 
and the variability of the flow velocity changes after infu- 
sion of acetylcholine. Statistical significance was defined as 
p < 0.05. All data were expressed as means zt SD. 
RESULTS 
Heart rate was stable throughout the study, with a 
significant increase only after the bolus injection of 
isosorbide dinitrate (Fig. 3, A). In two cases during 
the maximal infusion of acetylcholine brief episodes 
of Mobitz I atrioventricular block, which did not re- 
quire ventricular pacing, were observed. Aortic pres- 
sure was stable in baseline conditions and during the 
infusion of the different concentrations of acetylcho- 
line. A slight but significant decrease was observed at 
the peak effect of the papaverine and isosorbide di- 
nitrate infusions (-7 % and -5 % , respectively) (Fig. 
3, B). 
Flow velocity changes. Table I shows the individual 
changes in blood flow velocity in the studied patients. 
In Fig. 4 the changes of time-averaged peak blood 
flow velocity are expressed as a percent of the base- 
line velocity (baseline 2). A moderate decrease of 
blood flow velocity was observed between the first 
baseline measurement (beginning of the study) and 
the second and third baseline measurements (5 min- 
utes after infusion of papaverine and after infusion of 
the maximal concentration of acetylcholine, respec- 
tively, p < 0.05). On the contrary, a large increase was 
observed after papaverine injection, with a peak ve- 
locity 2.8 + 0.83 times higher than in basal condi- 
tions (baseline 2). The lowest concentration of ace- 
tylcholine did not induce significant changes in blood 
flow velocity. A 26% -t 60% increase was observed 
after 5 minutes of infusion of acetylcholine 10V7 
mol/L (p < 0.05). At the end of the infusion of the 
highest acetylcholine concentration (10m6 mol/L) a 
more than twofold increase in flow velocity was 
observed (+105% f 138%, p < 0.001). 
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Table 1. Clinical characteristics and flow velocity changes after papaverine and acetylcholine infusions 
Patient Age Cholesterol Wall 
No. (yr) Sex Hypertension (mmollL) Vessel irreg. 
1 70 M Y 5.5 LAD Y 
2 63 M N 5.7 RCA Y 
3 68 F Y 7.3 RCA Y 
4 58 M N 4.9 LCX Y 
5 49 M Y 5.8 LCX Y 
6 59 M N 6.5 LCX Y 
7 50 M N 6.4 RCA Y 
8 53 M Y 5.6 LCX Y 
9 48 M Y 7.2 LAD Y 
10 53 M N 5.5 LAD N 
11 66 F Y 7.7 LCX Y 
12 52 F N 7.4 LCX Y 
13 59 M N 6.6 LCX Y 
14 42 M N 5.2 LCX N 
15 54 F N 5.9 LCX Y 
16 45 M N 7.1 LCX Y 
17 45 M Y 6.1 LAD N 
18 44 M N 7.7 RCA Y 
19 67 M N 5.8 LAD N 
20 67 M N 6.9 RCA Y 
21 71 M N 4.7 RCA N 
22 45 F N 7.0 LAD N 
23 46 M Y 6.8 LAD N 
24 58 M N 5.4 RCA N 
25 66 M N 4.9 LCX Y 
26 69 M N 5.4 RCA Y 
27 65 M N 5.9 LCX N 
28 54 M Y 5.3 RCA N 
29 56 M N 7.1 LCX Y 
Mean 57 6.2 
*SD 9 0.9 
Ach, Acetylcholine; BAS, baseline; ISDN, isosorbide dinitritate; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; PAV, 
papaverine; RCA, right coronary artery. 
*p < 0.002 versus baseline 2. 
tp < 0.02 versus baseline 1. 
$p < 0.05 versus baseline 2. 
$p < 0.005 versus baseline 1. 
Time-response of the flow velocity change and flow 
velocity variability during acetylcholine infusion. In Fig. 
5 the time-response of the flow velocity changes dur- 
ing the infusion of the maximal concentration of ace- 
tylcholine is reported for the entire group (Fig. 5, A) 
and for all individual cases. A significant increase of 
flow velocity was observed within 30 seconds from the 
beginning of the infusion. Afterwards, during the re- 
maining infusion period, no significant flow velocity 
changes were observed in the study population over- 
all. However, if the individual response is considered, 
(Fig. 5, B) a relatively stable flow velocity was 
observed only in 10 patients during infusion. In the 
remaining patients, despite the constant rate of 
infusion and the stable hemodynamic conditions, a 
large variability was observed, with cases showing a 
progressive increase or decrease during the final 
phase of infusion (Fig. 5, C and D, respectively) or a 
bell-shaped or biphasic response (Fig. 5, E and F, re- 
spectively; example in Fig. 6). Cyclic variations of 
flow velocity were observed in the following minutes 
(Fig. 5). The variability was more evident in the pa- 
tients with a large velocity increase after acetylcho- 
line. 
Coronary artery cross-sectional area. Table II indi- 
cates the individual measurements of the mean 
cross-sectional area of the proximal and distal coro- 
nary segments. In Fig. 7 the changes in cross- 
sectional area after infusion of the three increasing 
concentrations of acetylcholine and the bolus of iso- 
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BASI PAV 
cmlsec cmlsec 
BASZ 
cmlsec 
Achl O+ 
cmlsec 
Ach10-7 
cm/see 
Achl O+ 
cmlsec 
BAS3 
cm/see 
ISDN 
cm/see 
22 44 22 21 18 20 21 30 
20 48 19 16 22 33 22 35 
19 40 20 20 21 32 24 22 
33 60 26 29 24 50 26 24 
44 79 26 25 25 23 23 28 
32 89 22 29 30 49 25 33 
11 41 14 19 19 26 15 24 
23 70 21 23 35 53 23 65 
17 39 17 22 41 66 20 32 
38 56 32 29 30 32 26 42 
27 65 20 19 20 37 16 26 
25 80 19 19 35 44 17 25 
22 52 24 26 28 46 24 38 
33 53 24 24 23 24 22 36 
28 71 28 28 27 43 28 43 
42 120 39 39 41 65 39 66 
27 77 25 25 32 48 26 29 
32 68 23 21 22 67 23 43 
27 70 17 19 25 31 19 22 
25 66 27 27 36 72 30 39 
25 57 21 19 34 69 23 23 
36 90 55 40 35 120 n.r. n.r. 
23 44 21 16 24 17 17 18 
26 66 24 20 20 18 21 30 
15 52 11 14 42 89 17 26 
28 65 28 28 27 29 25 40 
21 34 15 15 22 39 21 24 
12 43 9 10 9 15 9 21 
32 65 23 17 19 18 23 19 
26 62* 23t 23 27* 44* 23 32* 
8 18 8 7 8 24 5 12 
sorbide dinitrate are expressed as a percent of the 
basal cross-sectional area. The injection of the two 
lowest concentrations of acetylcholine induced a 
moderate but significant reduction of the mean 
cross-sectional area both in the proximal segment 
and in the distal segment. A larger decrease was ob- 
served after infusion of the highest concentration of 
acetylcholine (-24 % +- 20 % and -22 % f 20% of 
the mean cross-sectional area of the proximal and 
distal coronary segments, respectively, p < 0.00001). 
At this concentration almost all of the studied arter- 
ies showed a variable degree of vasoconstriction (26 
of 29 arteries, 90 % ), (Fig. 8, A). In no case was a mean 
cross-sectional area reduction of more than 75 % ob- 
served. At the end of the infusion of the highest con- 
centration of acetylcholine, focal vasoconstriction of 
the more distal branches of the studied artery was 
observed in eight patients. In these cases quantita- 
tive angiography also showed a more severe vasocon- 
striction (-32% f 25% vs -18% f 22% cross-sec- 
tional area reduction of the analyzed segments with 
and without focal arterial spasm, respectively,p = not 
significant). The presence of a preserved vasodilatory 
capacity of the studied artery was confirmed by the 
diffuse cross-sectional area increase after bolus in- 
jection of a direct smooth muscle vasodilator such as 
isosorbide dinitrate (+ 16% -t 26% and +18% f 
26 % cross-sectional area increase vs baseline for the 
proximal and distal coronary segments, respectively, 
both p < 0.002). 
Coronary flow changes. A significant increase of 
coronary flow was observed only after infusion of the 
maximal concentration of acetylcholine (+43 % + 
83 % , p < 0.001). The large variability in the individ- 
ual measurements for the highest concentrations of 
acetylcholine is shown in Fig. 8, B). Note that at the 
522 Di Mario et al. 
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Fig. 5. Temporal changes in flow velocity during infusion of the highest concentration of acetylcholine ex- 
pressed as a percent of the value before infusion (time 0). A, mean t SD. B, Ten individual curves showing 
a relatively stable flow velocity at baseline 3 (5 minutes after the end of the acetylcholine infusion). C and 
D, six and five patients showing, respectively, a progressive increase and a progressive decrease from the 
beginning to the end of the infusion. E and F, three and five cases with a bell-shaped or a biphasic response 
during infusion. 
peak concentration of acetylcholine, 10 patients 
showed a decrease of absolute flow and an increase in 
coronary resistance. 
Correlation of the observed results with the clinical- 
angiographic characteristics. The flow velocity, cross- 
sectional area, and flow changes after acetylcholine 
infusion showed no correlation with age, sex, pres- 
ence of systemic hypertension, total cholesterol, 
high-density lipoprotein (HDL) cholesterol, HDL 
cholesterol/total cholesterol ratio, plasma triglycer- 
ides, type of studied artery, and basal coronary lumi- 
nal diameter. The presence of wall irregularities was 
associated with a larger decrease in luminal cross- 
sectional area (-27 % * 20 % change vs baseline in 
the 19 arteries with angiographically visible wall ir- 
regularities and -16% f 20% in the angiographi- 
tally normal arteries). The difference, however, was 
not statistically significant. The arteries with wall ir- 
regularities also showed a smaller flow increase after 
the last concentration of acetylcholine (+47% t 
30% vs + 68% f 56% in the group with smooth ar- 
terial contours, p = not significant). 
A poor correlation was observed between flow ve- 
locity changes after acetylcholine and papaverine in- 
fusions (r2 = 0.18 for the maximal concentration of 
acetylcholine). Similarly, the percent increase of lu- 
men diameter after isosorbide dinitrate infusion was 
not correlated with the changes observed after ace- 
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Usefulness of changes in exercise tolerance 
induced by nitroglycerin in identifying patients 
with syndrome X 
Two exercise tests, one under basal conditions and one after sublingual nitroglycerin (NTG), 
were performed in 39 patients with stable angina pectoris-16 with critical coronary stenoses 
and 23 with normal coronary arteries (syndrome X). Under basal conditions, times at ischemic 
threshold, at peak exercise, and at complete ECG recovery were similar in the two groups. Peak 
ST depression was significantly higher in patients with coronary artery disease (CAD). In a 
similar proportion of patients, ST-segment depression developed earlier or at a low heart rate. 
Patterns of heart rate, blood pressure, and rate-pressure product during exercise and recovery 
were also similar. After NTG an increase in the ischemic threshold was observed in a 
significantly higher proportion of patients with CAD (93.8% vs 39.1%). Furthermore, a subgroup 
of patients with syndrome X showed a worsening of exercise performance. This suggests that 
NTG does not directly affect small coronary vessels. Our results confirm that no relevant 
differences exist in exercise responses between patients with CAD and those with syndrome X 
under basal conditions. NTG-induced changes in this response could be useful in identifying 
patients with normal coronary arteries. Moreover, this test could be used as a guide to 
therapeutic approaches. (AM HEART J 1994;127:531-5.) 
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Table II. Quantitative angiographic changes after acetylcholine infusion 
Mean diameter proximal segment (mm) Mean diameter distal segment (mm) 
Patient 
No. BAS Ach10-8 Ach10-7 AchlO+ ISDN BAS Achl O+ Ach10-7 AchlO-” ISDN 
1 1.89 1.74 1.65 1.58 1.84 1.24 1.30 1.20 1.14 1.46 
2 2.82 2.82 2.50 2.36 2.87 2.87 2.40 2.59 2.21 2.69 
3 2.36 2.33 2.67 2.35 3.05 2.74 2.71 2.57 2.35 3.02 
4 2.41 2.39 2.49 2.30 2.79 1.78 1.82 1.69 1.60 1.94 
5 2.48 2.09 2.15 1.99 2.60 1.74 1.50 1.34 1.36 1.8 
6 2.87 2.19 2.12 2.22 2.86 2.27 1.86 1.66 1.83 2.42 
7 4.00 4.08 4.13 4.28 4.21 2.23 1.95 1.89 1.92 2.06 
8 2.75 2.57 2.73 2.60 3.16 1.58 1.55 1.40 1.57 1.95 
9 1.48 1.28 1.41 1.15 1.54 1.17 0.97 1.12 1.10 1.44 
10 1.67 1.42 1.52 1.52 1.92 1.32 1.30 1.37 1.26 1.67 
11 3.00 2.98 2.85 2.62 3.06 1.40 1.42 1.39 1.21 1.47 
12 1.66 1.62 1.62 1.59 1.82 1.48 1.39 1.33 1.31 1.43 
13 2.30 n.a. 1.97 1.38 2.02 2.15 ma. 1.66 1.05 1.8 
14 2.91 2.90 3.00 2.85 2.90 1.66 1.66 1.82 1.77 1.67 
15 3.20 3.18 3.15 2.96 3.12 1.50 1.37 1.28 0.98 1.36 
16 3.11 2.77 2.59 2.43 3.41 1.42 1.21 1.29 1.32 1.71 
17 2.17 1.91 1.90 1.74 1.94 1.99 1.78 1.82 n.a. 1.77 
18 2.69 2.51 2.54 2.41 2.96 1.33 1.21 1.26 1.40 1.52 
19 2.59 2.28 2.23 2.07 2.62 1.60 1.32 1.31 1.30 1.76 
20 3.13 2.52 2.72 2.42 3.16 1.78 1.57 1.67 1.69 1.83 
21 2.96 3.27 3.14 3.15 3.57 1.71 1.73 1.54 1.60 2.08 
22 1.52 1.43 1.62 1.49 2.21 1.36 1.46 1.42 1.09 1.99 
23 2.22 2.24 2.06 2.12 2.26 1.76 1.76 1.74 1.88 2.12 
24 3.03 2.70 2.91 2.41 3.23 2.35 2.23 2.35 2.31 2.62 
25 2.28 1.90 1.77 1.39 2.37 1.66 1.55 1.48 1.18 1.94 
26 2.72 2.72 2.71 2.41 3.20 1.74 1.74 1.67 1.42 2.11 
27 2.47 2.40 1.96 1.91 2.63 1.11 1.17 0.95 1.09 1.23 
28 3.16 3.22 3.28 3.28 3.09 1.90 1.77 1.73 1.67 1.75 
29 2.47 2.26 2.18 1.81 2.68 1.46 1.31 1.29 1.29 1.56 
Mean 2.56 2.42* 2.39* 2.237 2.731 1.73 1.61* 1.58$ 1.50t 1.85* 
*SD 0.56 0.62 0.62 0.66 0.60 0.43 0.38 0.39 0.38 0.42 
Adz, Acetylcholine; BAS, baseline; ISDN, isosorbide dinitrate 
*p < 0.002 versus baseline. 
tp < 0.00001 versus baseline. 
$p < 0.0005 versus baseline. 
tylcholine infusion. The flow changes and flow resis- 
tance changes after the maximal dose of acetylcho- 
line infusion showed a poor correlation with the 
cross-sectional area changes observed in the proxi- 
mal/distal coronary segments. Fig. 9 shows the linear 
regression analysis performed with the use of the 
cross-sectional area changes of the proximal seg- 
ments. Also, in the distal coronary segment analyzed 
a very poor correlation was observed, with a squared 
correlation coefficient of 0.01 and 0.05 for coronary 
flow and flow resistance. 
DISCUSSION 
Acetylcholine is the prototype and the most fre- 
quently used pharmacologic stimulus with a primary 
endothelium-independent contractile action on the 
vascular smooth muscle cells and an opposite endo- 
thelium-mediated vasodilatory activity, which is pre- 
dominant in normal conditions and at physiologic 
concentrations.378 38 Acetylcholine was used in the in 
vitro experiments in which the role of intact endo- 
thelium in the regulation of vascular tone was estab- 
lishedl and in the first in vivo study showing that 
acetylcholine induces severe vasospasm in human 
coronary arteries with significant stenoses.6 The in- 
duction of an endothelium-dependent vasodilatation 
in canine femoral3g and coronary40 arteries after the 
application of acetylcholine on the arterial adventi- 
tia suggests a role of acetylcholine, the mediator of 
the parasympathetic stimulation, in the modulation 
of vascular tone. The circadian rhythm of the para- 
sympathetic activity has been suggested as an expla- 
nation for the higher incidence in the early morning 
of acute coronary syndromes, such as vasospastic an- 
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Fig. 8. Cross-sectional area (CSA) and coronary blood flow (CBF) in baseline conditions (baseline 2) and 
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gina and myocardial infarction, Selective intracoro- 
nary infusion of acetylcholine elicited vascular re- 
sponses comparable to those observed after adminis- 
tration of serotonin,4l a substance that is released 
after platelet activation and may contribute to the 
development of myocardial ischemia in acute coro- 
nary syndromes.17, 42, 43 
In this study concentrations and flow rate of ace- 
tylcholine were the same as those used in recent re- 
portsi 20, 23 in order to facilitate the comparison of 
results. Papaverine and isosorbide dinitrate were 
infused selectively in doses sufficient to induce a 
maximal vasodilatation of the resistance and con- 
ductance coronary arteries with a limited systemic 
effect.44 With these drugs, the presence of an aspe- 
cific impairment of vascular relaxation caused by 
structural changes of the epicardial and resistance 
coronary vessels could be excluded. 
Cross-sectional area changes. The arteries studied 
included both angiographically normal and mini- 
mally diseased arteries. In this latter group the 
severity of coronary vasoconstriction was similar to 
that reported in two comparable series of patients by 
Zeihereta1.16,s3(-27% d ecrease in the present study 
vs -29% and -34 % cross-sectional area decrease 
from baseline at the same concentration of acetyl- 
choline). The angiographically normal arteries 
showed a 16% decrease in cross-sectional area from 
baseline, similar to the 23% decrease reported by 
Vrints et a1.12 for normal segments of the left anterior 
descending coronary artery at this concentration. In 
the present study the arteries without angiographi- 
tally visible lesions showed a less pronounced vaso- 
constriction after infusion of the maximal concen- 
tration of acetylcholine. No significant differences 
were present, however, between arteries with and 
without angiographically visible wall irregularities. A 
possible explanation is that the atherogenic factors, 
which have already induced a severe symptomatic 
coronary stenosis in our study population, can be 
sufficient to induce the development of diffuse endo- 
thelial damage also in the absence of evident athero- 
sclerotic changes. An alternative explanation is that 
angiography is not sufficiently sensitive to detect ini- 
tial atherosclerotic changes. Epicardial and intracor- 
onary ultrasound imaging have shown that diffuse 
atherosclerotic changes are present in patients with 
coronary artery disease also in segments that have an 
angiographically normal lumen and smooth vascular 
contours.45-47 Pathologic reports have explained this 
phenomenon with the presence of an overall vascular 
enlargement able to preserve a normal vascular 
lumen despite large areas of wall encroachment.48 In 
this study no patient showed a severe focal or diffuse 
spasm that induced a critical flow reduction and the 
development of symptoms and signs of myocardial 
ischemia. The characteristics of the studied popula- 
tion, including only patients with stable angina and 
for the vast majority single-vessel coronary disease, 
may explain the different results observed in previ- 
ous studies, which report frequent episodes of severe 
vasoconstriction after acetylcholine.7, 11, 22 The ab- 
sence of more than 75% cross-sectional area reduc- 
tion from the basal measurement suggests that the 
impairment of flow after acetylcholine infusion is not 
due to a critical vasoconstriction of the epicardial ar- 
teries. A flow limitation caused by focal or diffuse 
vasoconstriction of small distal branches, not ana- 
lyzable with quantitative angiography but visually 
detectable in eight cases, is more difficult to rule out. 
In these patients, however, the flow changes after 
infusion of the maximal concentration of acetylcho- 
line were similar to those observed in the remaining 
cases. 
Diffuse vasoconstriction was present after infusion 
of the maximal concentration of acetylcholine in 90 ?;, 
of the patients studied (26 of 29). A progressive dose 
response was observed with increasing concentra- 
tions of acetylcholine. The proximal and distal seg- 
ments showed a similar decrease of lumen dimension. 
A moderate difference between proximal and distal 
segments was observed only after the intermediate 
concentration of acetylcholine (cross-sectional area 
decrease from baseline -12 % + 17 OGfl in the proximal 
segment and -15% + 15% in the distal segment, 
p < 0.05). At the peak concentration of acetylcholine, 
however, no differences were observed between prox- 
imal and distal arterial segments. Vrints et a1.12 have 
confirmed the presence of similar changes of proxi- 
mal and distal segments of the left anterior descend- 
ing coronary artery. A more significant vasoconstric- 
tion after infusion of acetylcholine of the distal 
coronary segments was reported by Dubois-Rande et 
a1.4g in a very limited patient population (five cases). 
The variability of the response to acetylcholine of the 
proximal and distal segments observed in individual 
patients can explain this difference and probably re- 
flects a different severity of atherosclerotic involve- 
ment of the two segments. 
Coronary flow and flow velocity changes. Intracoro- 
nary Doppler echography was used to assess coronary 
flow velocity in this study. Technical improvements 
have recently increased the reliability of this tech- 
nique for the assessment of coronary flow velocity. In 
particular, the large Doppler sample volume and the 
use of peak blood flow velocity, allowed by the spec- 
tral analysis of the signal, avoid changes of the mea- 
sured velocity in response to minor variations of the 
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position of the Doppler probe inside the artery. It was 
thus possible to minimize manipulation and reposi- 
tioning of the Doppler probe and to avoid excluding 
patients because of poor quality of the Doppler 
recordings. The accuracy in the calculation of abso- 
lute coronary flow from the corresponding mean flow 
velocity and cross-sectional area, however, is still 
limited by the difficulty of obtaining an exact mea- 
surement of the mean velocity and by the inability to 
acquire the two measurements simultaneously. In the 
presence of rapid changes of flow and cross-sectional 
area such as those after the injection of a bolus of ni- 
trates, papaverine, or adenosine, the delay between 
flow velocity measurement and cineangiogram may 
result in a significant inaccuracy of the flow mea- 
surements. In this study no cineangiograms were 
performed at the maximal effect of the injection of 
papaverine. For this reason, absolute coronary flow 
after papaverine infusion could not be calculated. 
The presence of a larger cross-sectional area at the 
peak effect of papaverine than in baseline conditions 
may explain the relatively low coronary flow reserve 
(2.8 f 0.8) observed in this study. On the basis of 
previously reported angiographic measurements af- 
ter papaverine infusion, a 15 % to 20 % underestima- 
tion of the true flow reserve is expected.50, 51 In this 
study, however, papaverine was used only to confirm 
a normal response of the coronary resistance vessels 
to a direct smooth muscle vasodilator to exclude 
structural alterations of the microvasculature as the 
factor limiting the flow increase. 
The lack of simultaneous flow velocity/cross-sec- 
tional area measurements is also a serious limitation 
in explaining the changes observed during infusion of 
acetylcholine. Variations of flow velocity during in- 
fusion of acetylcholine have not been previously re- 
ported. With the previous generation of Doppler 
probes, the Doppler signal was highly dependent on 
minor changes in the position of the Doppler sample 
volume.5” These changes therefore could have been 
misinterpreted as artifacts because of an unstable 
position of the catheter in the artery. The previously 
described characteristics of the Doppler guide wire 
and the modalities of signal analysis (fast Fourier 
transform, continuous automatic measurement of 
peak flow velocity) are ideal conditions for the 
assessment of these moderate flow velocity varia- 
tions. Two causes can be suggested for these flow ve- 
locity variations: a true change in flow as the result of 
a variable vasodilatation of the resistance vessels 
over time or a change of the cross-sectional area at the 
site of the Doppler sample volume (flow velocity 
changes but coronary flow remains the same). In the 
absence of a simultaneous continuous assessment of 
lumen cross-sectional area, the mechanism of these 
flow velocity changes remains speculative. In the near 
future the combination of intravascular imaging and 
Doppler ultrasound may allow a continuous assess- 
ment of coronary cross-sectional area and flow veloc- 
ity and facilitate the assessment of the dynamics of 
the flow-area changes after acute pharmacologic in- 
terventions.53 
In this study the flow velocity changes after ace- 
tylcholine infusion have been expressed as a percent 
change from baseline and not as a percent of the 
maximal flow increase (after papaverine infusion) 
because a moderate (-7 % ) but significant aortic 
pressure reduction was observed at the peak effect of 
papaverine. A constant pressure is a prerequisite for 
a reliable comparison of a flow measured in autoreg- 
ulatory conditions and during maximal vasodilata- 
tion.54 Recently, the slope of the instantaneous 
hyperemic diastolic pressure-flow relationship has 
been used in animal experiments as an index of cor- 
onary conductance and has been shown to be inde- 
pendent of changes in aortic pressure, heart rate, and 
cardiac contractility. 55, 56 The instantaneous hypere- 
mic diastolic pressure-flow velocity relationship can 
be reproducibly assessed also in human beings.57, 58 
The possibility of measuring an index of coronary 
conductance independent of the hemodynamic con- 
ditions at the time of assessment during different 
pharmacologic interventions and during maximal 
vasodilatation is of great potential interest (Fig. 10). 
This approach, however, still requires more extensive 
clinical validation. 
Experimental data have demonstrated that ath- 
erosclerotic animals show an abnormal endothelium- 
dependent vasodilatation of the coronary resistance 
arteries, despite the absence of structural atheroscle- 
rotic lesions.24 The comparison of the flow response 
to acetylcholine in patients with coronary artery dis- 
ease and in control subjects has confirmed an im- 
paired flow increase in the patients with coronary ar- 
tery disease, despite the absence of significant lesions 
of the epicardial coronary arteries.23 In this study a 
large variability in the flow changes was observed af- 
ter infusion of the highest doses of acetylcholine. A 
dose-dependent vasodilatation after acetylcholine 
infusion was present in most cases, with flow increase 
up to three times the baseline flow. In 10 patients, 
however, a flow decrease was observed after infusion 
of the maximal concentration of acetylcholine. The 
mean flow increase from baseline was +44 % f 24 % 
at the maximal concentration of acetylcholine, an in- 
crease much lower than the flow increase observed in 
normal control subjects at the same acetylcholine 
concentration.33* 5g No clinical or angiographic pre- 
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Fig. 10. Pressure-flow velocity loop of 4 consecutive beats at peak effect of injection of papaverine and af- 
ter 5 minutes of infusion of highest concentration of acetylcholine. Regression line has been calculated from 
middiastolic data points. Note steeper slope of pressure-velocity relationship after papaverine infusion and 
lower pressure intercept. 
dictors of these large individual differences could be 
observed. 
A reduction of the endothelium-dependent relax- 
ation is present in animals chronically maintained on 
an atherogenic diet with a high content of cholester- 
o~.~O> 61 In patients with hypercholesterolemia with- 
out angiographic evidence of coronary artery disease, 
impaired endothelium-mediated vasodilatation of 
the epicardial coronary arteries and of the resistance 
coronary vessels has been demonstrated.i6 Thirteen 
of the study patients had a total cholesterol level of 
6.4 mmol/L or (250 mg/dl) greater. This group, how- 
ever, showed no significant differences in terms of 
flow increase and vascular diameter changes after 
acetylcholine infusion. The importance of the rela- 
tive amounts of HDL and low-density lipoprotein 
cholesterol has recently been reported to correlate 
more closely than total cholesterol with the degree of 
impairment of the endothelium-mediated vasodila- 
tation. In the studied group, however, the use of the 
HDL/total cholesterol ratio did not identify a subset 
of patients with a different response to acetylcholine. 
Correlation of coronary area-flow changes after ace- 
tylcholine infusion. In this study mean arterial cross- 
sectional area of the epicardial arteries and coronary 
flow have been considered as independent indices of 
response of conductance and resistance coronary 
vessels. This assumption has three potential limita- 
tions: (1) the possibility that a flow-limiting vaso- 
constriction occurs in an epicardial artery, (2) the 
development of a vasodilatation of the epicardial ar- 
teries secondary to the increase of flow, and (3) the 
use of a cross-sectional area measured along the an- 
alyzed segment to calculate coronary flow. In spite of 
all these potential reasons for interdependence, the 
flow or flow resistance changes after infusion of the 
maximal concentration of acetylcholine showed only 
a poor correlation with the corresponding cross-sec- 
tional area changes. The discrepancy between flow 
and cross-sectional area reflects a different response 
of the conductance and resistance arteries to acetyl- 
choline. The large arteries are the preferential target 
of the atherosclerotic process. At this level the pres- 
ence of intimal thickening may constitute a barrier to 
the diffusion of nitric oxide from the endothelial cells 
to the muscular media. 63 A macrophagic infiltration 
or the presence of a lipidic component of the intimal 
plaque may also accelerate the degradation of nitric 
oxide and prevent its action on the underlying mus- 
cular layer. 37 The importance of these mechanisms in 
atherosclerotic human arteries is indirectly con- 
firmed by the frequent development of focal vaso- 
constriction after acetylcholine infusion. Myocardial 
perfusion is regulated predominantly by resistance 
arteries with a diameter of less than 200 pm.64 These 
arteries do not show signs of atherosclerotic involve- 
ment as determined by histologic examination, sug- 
gesting that biochemical or ultrastructural changes 
are the most likely mechanisms underlying the ab- 
normal endothelium-dependent relaxation. These 
observations have potential clinical implications. 
Prolonged treatment aimed at the regression of the 
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atherosclerotic intimal changes may be required to 
restore an impaired endothelium-mediated response 
when the presence of an intimal barrier is the main 
operative mechanism. 65-67 On the contrary, acute 
pharmacologic interventions or brief treatment may 
be sufficient to normalize the endothelial function 
when metabolic abnormalities are involved. The 
possibility of normalizing the endothelial response in 
hypercholesterolemia with a short-term infusion of 
L-arginine has been shown in animal experiments,68 
as well as in human coronary arteries.4gy 6g Similarly, 
different classes of drugs have shown the ability to 
restore a normal endothelium-mediated vascular re- 
activity in experimental animals.70-72 
Conclusions. In angiographically normal or mini- 
mally diseased arteries of patients with symptomatic 
coronary artery disease, very low doses of acetylcho- 
line induced a significant coronary vasoconstriction 
of the epicardial coronary arteries. The resistance 
vessels showed a variable response, with a trend to- 
ward moderate vasodilatation (flow increase in two of 
three of the patients after infusion of the highest 
concentration of acetylcholine). The presence of hy- 
percholesterolemia or wall irregularities was not cor- 
related with the diameter/flow changes after acetyl- 
choline infusion. The poor correlation observed 
between cross-sectional area and flow changes after 
acetylcholine infusion suggests that different mech- 
anisms induce impairment of endothelium-mediated 
vasodilatation in conductance and resistance coro- 
nary vessels. 
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Usefulness of changes in exercise tolerance 
induced by nitroglycerin in identifying patients 
with syndrome X 
Two exercise tests, one under basal conditions and one after sublingual nitroglycerin (NTG), 
were performed in 39 patients with stable angina pectoris-16 with critical coronary stenoses 
and 23 with normal coronary arteries (syndrome X). Under basal conditions, times at ischemic 
threshold, at peak exercise, and at complete ECG recovery were similar in the two groups. Peak 
ST depression was significantly higher in patients with coronary artery disease (CAD). In a 
similar proportion of patients, ST-segment depression developed earlier or at a low heart rate. 
Patterns of heart rate, blood pressure, and rate-pressure product during exercise and recovery 
were also similar. After NTG an increase in the ischemic threshold was observed in a 
significantly higher proportion of patients with CAD (93.8% vs 39.1%). Furthermore, a subgroup 
of patients with syndrome X showed a worsening of exercise performance. This suggests that 
NTG does not directly affect small coronary vessels. Our results confirm that no relevant 
differences exist in exercise responses between patients with CAD and those with syndrome X 
under basal conditions. NTG-induced changes in this response could be useful in identifying 
patients with normal coronary arteries. Moreover, this test could be used as a guide to 
therapeutic approaches. (AM HEART J 1994;127:531-5.) 
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